A patient has a rapidly developing blister that is not improving with antiviral therapy and is worsening—what is the appropriate evaluation and management?

When Blisters Worsen Despite Antiviral Therapy: Immediate Action Required

If blisters develop suddenly and worsen despite antiviral treatment, immediately suspect either antiviral-resistant herpes simplex virus (HSV)/varicella-zoster virus (VZV), bacterial superinfection (particularly MRSA), or an alternative non-viral diagnosis such as an autoimmune blistering disorder.

Critical First Steps: Diagnostic Workup

Obtain Cultures and Biopsies Immediately

• Swab lesions for bacterial culture with specific request for MRSA testing 1, 2
• Obtain viral culture with antiviral susceptibility testing if HSV/VZV suspected 2
• Perform two skin biopsies: one for routine histopathology and one for direct immunofluorescence (sent unfixed) to exclude autoimmune blistering diseases like pemphigus vulgaris or bullous pemphigoid 3, 4
• Consider PCR testing for HSV and VZV in blood if disseminated infection suspected 5

Assess Immune Status

Antiviral resistance occurs almost exclusively in immunocompromised patients 2, 6. Determine if the patient has:

• HIV infection
• Active chemotherapy or recent transplantation
• Chronic corticosteroid use or other immunosuppressive medications
• Diabetes mellitus (functional immunosuppression) 7
• Advanced age (≥65 years increases complication risk) 8

Treatment Algorithm Based on Clinical Scenario

Scenario 1: Suspected Antiviral-Resistant HSV/VZV

For immunocompromised patients with chronic, non-healing ulcerations despite 7-10 days of standard antiviral therapy 2, 9:

1. Switch to IV foscarnet immediately: 40 mg/kg three times daily or 60 mg/kg twice daily for 10 days 9
2. For accessible mucocutaneous lesions, apply topical trifluridine (TFT) ophthalmic solution 3-4 times daily as adjunct 9
3. If foscarnet fails, use IV cidofovir or compounded 1-3% topical cidofovir 9

Key caveat: Oral acyclovir, valacyclovir, and famciclovir share cross-resistance patterns—escalating oral doses will not work if true resistance exists 2, 9.

Scenario 2: Bacterial Superinfection (Most Common Cause of Worsening)

If lesions show increased exudate, crusting, or surrounding erythema 1, 10:

1. Start empiric MRSA coverage immediately while awaiting cultures:

   • IV vancomycin 30-60 mg/kg/day in divided doses (target trough 15-20 μg/mL) 1, 5
   • Alternative: linezolid 600 mg IV/PO every 12 hours 1, 5
   • Alternative: daptomycin 4-6 mg/kg/day IV 5

2. Continue antiviral therapy alongside antibiotics—do not stop antivirals when adding antibacterial coverage 10

3. Adjust antibiotics based on culture results; MRSA superinfection complicates herpes zoster in up to 21% of cases 10

Scenario 3: Alternative Diagnosis (Autoimmune Blistering Disease)

If direct immunofluorescence shows IgG/C3 deposition 3, 4:

• Pemphigus vulgaris: Start high-dose systemic corticosteroids (prednisolone 0.5-1 mg/kg/day) 3
• Stevens-Johnson syndrome/TEN: Discontinue ALL potential culprit drugs immediately, transfer to burn unit or intensive care 4
• These conditions do not respond to antivirals and will worsen without immunosuppressive therapy

Special Considerations for Immunocompromised Hosts

In patients with cellular immune defects (transplant recipients, lymphoma, anti-TNF therapy) 5:

• Empirically add antifungals (voriconazole or lipid amphotericin B) if fever persists despite antibacterials and antivirals 5
• Aspergillus and Mucor can cause cutaneous lesions mimicking infected blisters
• Obtain dermatology consultation immediately—these patients require aggressive biopsy and surgical debridement 5

Common Pitfalls to Avoid

1. Do not simply increase oral acyclovir/valacyclovir doses in true antiviral resistance—switch to foscarnet 2, 9

2. Do not assume all worsening is viral—bacterial superinfection is more common than antiviral resistance in immunocompetent patients 1, 10

3. Do not delay biopsy when diagnosis uncertain—autoimmune blistering diseases require fundamentally different treatment and can be fatal if mismanaged 3, 4

4. Do not overlook disseminated VZV in elderly diabetic patients—can cause visceral involvement including gastric ulcers without typical dermatomal distribution 7

5. In patients already on prophylactic acyclovir/valacyclovir who develop new lesions, antiviral resistance must be investigated immediately 2